Company Announcements

LTR Pharma Unveils Erectile Dysfunction Nasal Spray

LTR Pharma Limited (AU:LTP) has released an update.

LTR Pharma Ltd has announced a fast-acting nasal spray for treating erectile dysfunction, aiming to provide investors with an overview of the company’s latest development. However, they caution that the presentation should not be seen as complete information for making investment decisions and contains forward-looking statements that are subject to various risks. The company disclaims any responsibility for the accuracy or completeness of the information provided.

For further insights into AU:LTP stock, check out TipRanks’ Stock Analysis page.

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App